These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32479683)

  • 1. Role of Platelet C-Type Lectin-Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma.
    Ichikawa J; Ando T; Kawasaki T; Sasaki T; Shirai T; Tsukiji N; Kimura Y; Aoki K; Hayakawa K; Suzuki-Inoue K; Saitoh M; Haro H
    J Bone Miner Res; 2020 Sep; 35(9):1738-1750. PubMed ID: 32479683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
    Takagi S; Sato S; Oh-hara T; Takami M; Koike S; Mishima Y; Hatake K; Fujita N
    PLoS One; 2013; 8(8):e73609. PubMed ID: 23991201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
    Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
    Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Podoplanin for the Treatment of Osteosarcoma.
    Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
    Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
    Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
    J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
    Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
    Sheng M; Sun R; Fu J; Lu G
    BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma.
    Kaneko MK; Oki H; Ogasawara S; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):154-61. PubMed ID: 26090592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
    Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
    Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
    Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
    J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet CLEC-2 and podoplanin in cancer metastasis.
    Lowe KL; Navarro-Nunez L; Watson SP
    Thromb Res; 2012 Apr; 129 Suppl 1():S30-7. PubMed ID: 22682130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
    Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
    J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
    Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
    Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
    Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.
    Miyata K; Takagi S; Sato S; Morioka H; Shiba K; Minamisawa T; Takami M; Fujita N
    Cancer Med; 2014 Dec; 3(6):1595-604. PubMed ID: 25132683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.